Sanofi's Genzyme Announces New Analysis Suggests Aubagio Slows Brain Atrophy in People with Relapsing MS
October 07, 2015 at 05:17 AM EDT
Genzyme, a Sanofi (NYSE: SNY) company, announced today that magnetic resonance imaging (MRI) data from the Phase III TEMSO study ...